Reinfection following successful direct-acting antiviral therapy for hepatitis C virus infection among people with recent injecting drug use: the SHARP-C study.
Ang J, Hajarizadeh B, Tillakeratne S, Dore GJ, Treloar C, Amin J, van Dyk J, Degenhardt L, Applegate T, Dunlop A, Fraser C, Conway B, Wong A, Fuchs D, Powis J, Mason K, Gane EJ, Weltman M, Read P, Martinello M, Rowe E, Baker DA, Wade A, Matthews G, Lafferty L, Lloyd A, Grebely J, Cunningham EB.
Ang J, et al. Among authors: baker da.
Int J Drug Policy. 2025 Sep;143:104859. doi: 10.1016/j.drugpo.2025.104859. Epub 2025 Jun 18.
Int J Drug Policy. 2025.
PMID: 40554239
Free article.